J. Coelho, T. Rebelatto, Rodrigo R. Pereira, P. Liedke, A. B. Zanon, S. Azevedo
{"title":"阿替佐利单抗单药治疗晚期BRAFV600野生型黑色素瘤","authors":"J. Coelho, T. Rebelatto, Rodrigo R. Pereira, P. Liedke, A. B. Zanon, S. Azevedo","doi":"10.33696/haematology.2.034","DOIUrl":null,"url":null,"abstract":"Juliano C. Coelho1,2*, Taiane F. Rebelatto1,2, Rodrigo R. Pereira1,2,3, Pedro E. R. Liedke1,2,3, Andrea B. Zanon1, Sergio J. Azevedo1,2,3 1Unidade de Pesquisa Clínica em Oncologia, Porto Alegre, Brazil 2Oncology Department, Oncoclinicas Group, Porto Alegre, Brazil 3Department of Oncology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil *Correspondence should be addressed to Juliano C. Coelho; juliano.oncologia@gmail.com","PeriodicalId":87297,"journal":{"name":"Journal of clinical haematology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Atezolizumab Monotherapy as First-line Treatment in Patients with Advanced BRAFV600 Wild-type Melanoma\",\"authors\":\"J. Coelho, T. Rebelatto, Rodrigo R. Pereira, P. Liedke, A. B. Zanon, S. Azevedo\",\"doi\":\"10.33696/haematology.2.034\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Juliano C. Coelho1,2*, Taiane F. Rebelatto1,2, Rodrigo R. Pereira1,2,3, Pedro E. R. Liedke1,2,3, Andrea B. Zanon1, Sergio J. Azevedo1,2,3 1Unidade de Pesquisa Clínica em Oncologia, Porto Alegre, Brazil 2Oncology Department, Oncoclinicas Group, Porto Alegre, Brazil 3Department of Oncology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil *Correspondence should be addressed to Juliano C. Coelho; juliano.oncologia@gmail.com\",\"PeriodicalId\":87297,\"journal\":{\"name\":\"Journal of clinical haematology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-10-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical haematology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33696/haematology.2.034\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical haematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33696/haematology.2.034","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
Juliano C.Coelho1,2*、Taiane F.Rebelatto1,2、Rodrigo R.Pereira 1,2,3、Pedro E.R.Liedke1,2,3,Andrea B.Zanon1、Sergio J.Azevedo1,2,3 1巴西阿雷格里港肿瘤研究所2肿瘤科,肿瘤临床组,阿雷格里港3巴西阿雷格雷港Clínicas de Porto Alegre医院肿瘤科*应联系Juliano C。兔子juliano.oncologia@gmail.com
Atezolizumab Monotherapy as First-line Treatment in Patients with Advanced BRAFV600 Wild-type Melanoma
Juliano C. Coelho1,2*, Taiane F. Rebelatto1,2, Rodrigo R. Pereira1,2,3, Pedro E. R. Liedke1,2,3, Andrea B. Zanon1, Sergio J. Azevedo1,2,3 1Unidade de Pesquisa Clínica em Oncologia, Porto Alegre, Brazil 2Oncology Department, Oncoclinicas Group, Porto Alegre, Brazil 3Department of Oncology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil *Correspondence should be addressed to Juliano C. Coelho; juliano.oncologia@gmail.com